Evidence map›Paper›PMID 36750687›Full record

ArticleCommunications medicine2023

Cardiothoracic ratio values and trajectories are associated with risk of requiring dialysis and mortality in chronic kidney disease.

Che-Yi Chou, Charles C N Wang, Hsiu-Yin Chiang, Chien-Fong Huang, Ya-Luan Hsiao, Chuan-Hu Sun, Chun-Sheng Hu, Min-Yen Wu, Sheng-Hsuan Chen, Chun-Min Chang and 6 more

Abstract read
In one paragraph

Article in Communications medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Observational
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Che-Yi ChouDivision of Nephrology, Department of Internal Medicine, Asia University Hospital, Wufeng, Taichung, Taiwan.
Charles C N WangDepartment of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan.
Hsiu-Yin ChiangBig Data Center, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan. T32031@mail.cmuh.org.tw.
Chien-Fong HuangBig Data Center, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
Ya-Luan HsiaoDepartment of Health Administration, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, USA.
Chuan-Hu SunBig Data Center, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
Chun-Sheng HuBig Data Center, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
Min-Yen WuBig Data Center, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.ORCID http://orcid.org/0000-0002-9197-0250
Sheng-Hsuan ChenBig Data Center, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
Chun-Min ChangDepartment of Electrical and Computer Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Yu-Ting LinBig Data Center, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
Jie-Sian WangDivision of Nephrology, Department of Internal Medicine, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
Yu-Cuyan HongDivision of Nephrology, Department of Internal Medicine, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
I-Wen TingDivision of Nephrology, Department of Internal Medicine, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
Hung-Chieh YehDivision of Nephrology, Department of Internal Medicine, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan.
Chin-Chi KuoDivision of Nephrology, Department of Internal Medicine, China Medical University Hospital and College of Medicine, China Medical University, Taichung, Taiwan. chinchik@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognostic role of the cardiothoracic ratio (CTR) in chronic kidney disease (CKD) remains undetermined.

methodsWe conducted a retrospective cohort study of 3117 patients with CKD aged 18-89 years who participated in an Advanced CKD Care Program in Taiwan between 2003 and 2017 with a median follow up of 1.3(0.7-2.5) and 3.3(1.8-5.3) (IQR) years for outcome of end-stage renal disease (ESRD) and overall death, respectively. We developed a machine learning (ML)-based algorithm to calculate the baseline and serial CTRs, which were then used to classify patients into trajectory groups based on latent class mixed modelling. Association and discrimination were evaluated using multivariable Cox proportional hazards regression analyses and C-statistics, respectively.

resultsThe median (interquartile range) age of 3117 patients is 69.5 (59.2-77.4) years. We create 3 CTR trajectory groups (low [30.1%], medium [48.1%], and high [21.8%]) for the 2474 patients with at least 2 CTR measurements. The adjusted hazard ratios for ESRD, cardiovascular mortality, and all-cause mortality in patients with baseline CTRs ≥0.57 (vs CTRs <0.47) are 1.35 (95% confidence interval, 1.06-1.72), 2.89 (1.78-4.71), and 1.50 (1.22-1.83), respectively. Similarly, greater effect sizes, particularly for cardiovascular mortality, are observed for high (vs low) CTR trajectories. Compared with a reference model, one with CTR as a continuous variable yields significantly higher C-statistics of 0.719 (vs 0.698, P = 0.04) for cardiovascular mortality and 0.697 (vs 0.693, P < 0.001) for all-cause mortality.

conclusionsOur findings support the real-world prognostic value of the CTR, as calculated by a ML annotation tool, in CKD. Our research presents a methodological foundation for using machine learning to improve cardioprotection among patients with CKD.

Identifiers

PMID36750687
PMCPMC9905092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.